Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral: Vanier Canada Graduate Scholarships

McGill University

$150,000.00

Network modeling of Alzheimer's disease progression: Using multimodal neuroimaging to test whether Alzheimer's pathology spreads through existing brain networks

EF 2016-17

Résumé
Amyloid-beta (AB) plaques and tau tangles are pathologies that are present in large concentrations in the brains of patients with Alzheimer's disease (AD). Additionally, AD is also characterized by loss of large amounts of brain tissue. Neuroimaging techniques allow scientists to measure these disease markers in living humans. By combining information from several different types of neuroimaging measures, complicated relationships between normal brain processes and disease process can be better understood. These "multimodal" analyses have led recently to the hypothesis that disease processes spread from one part of the brain to another over time, and that the pattern of spread is not random. Specifically, brain regions that are more affected by different pathologies also have a greater number of physical connections in the brain. Recent research has used mathematical models to test whether this hypothesis is valid, and to try to predict the ordering of biological events that leads to dementia. One such model, called the Epidemic Spreading Model (ESM), has used data from multiple neuroimaging tools to predict the spreading of AB in the brain. The model identifies an "epicenter", or a starting point of disease spread, and simulates where and when AB will move from this epicenter to other brain regions, based on how connected the regions are to one another. The ESM predicted the spread of AB with unprecedented accuracy, however a more complete picture of the biology of AD will require modeling the other hallmarks of the disease, namely tau and loss of brain tissue. The current project will adapt the ESM to neuroimaging techniques that measure where tau and brain tissue loss occur. Applying the ESM to these additional disease markers will help us empirically test, a) do these disease markers indeed spread through connected brain regions over time, b) if so, which specific brain networks are the most vulnerable and when, c) what areas are affected first.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
362797
Name
Vogel Jacob
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Network modeling of Alzheimer's disease progression: Using multimodal neuroimaging to test whether Alzheimer's pathology spreads through existing brain networks
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Alzheimer'S Disease; Brain Networks; Computational Models; Multimodal Neuroimaging
Abstract
Amyloid-beta (AB) plaques and tau tangles are pathologies that are present in large concentrations in the brains of patients with Alzheimer's disease (AD). Additionally, AD is also characterized by loss of large amounts of brain tissue. Neuroimaging techniques allow scientists to measure these disease markers in living humans. By combining information from several different types of neuroimaging measures, complicated relationships between normal brain processes and disease process can be better understood. These "multimodal" analyses have led recently to the hypothesis that disease processes spread from one part of the brain to another over time, and that the pattern of spread is not random. Specifically, brain regions that are more affected by different pathologies also have a greater number of physical connections in the brain. Recent research has used mathematical models to test whether this hypothesis is valid, and to try to predict the ordering of biological events that leads to dementia. One such model, called the Epidemic Spreading Model (ESM), has used data from multiple neuroimaging tools to predict the spreading of AB in the brain. The model identifies an "epicenter", or a starting point of disease spread, and simulates where and when AB will move from this epicenter to other brain regions, based on how connected the regions are to one another. The ESM predicted the spread of AB with unprecedented accuracy, however a more complete picture of the biology of AD will require modeling the other hallmarks of the disease, namely tau and loss of brain tissue. The current project will adapt the ESM to neuroimaging techniques that measure where tau and brain tissue loss occur. Applying the ESM to these additional disease markers will help us empirically test, a) do these disease markers indeed spread through connected brain regions over time, b) if so, which specific brain networks are the most vulnerable and when, c) what areas are affected first.
Competitiondate
201611
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Vogel, Jacob
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~